Related Experiment Videos
Imprinting in Albright's hereditary osteodystrophy
1Institute of Medical Genetics, University Hospital of Wales, Heath Park, Cardiff.
Journal of Medical Genetics
|February 1, 1993
Summary
Albright's hereditary osteodystrophy (AHO) shows more maternal transmission. Maternal inheritance leads to full AHO expression, while paternal inheritance results in partial AHO, suggesting genomic imprinting.
Area of Science:
- Genetics
- Endocrinology
- Developmental Biology
Background:
- Albright's hereditary osteodystrophy (AHO) is a genetic disorder characterized by specific physical features.
- Previous observations suggested a potential difference in inheritance patterns.
- Hormone resistance, particularly pseudohypoparathyroidism, is a key clinical feature associated with AHO.
Purpose of the Study:
- To investigate the pattern of inheritance in Albright's hereditary osteodystrophy (AHO).
- To explore the role of genomic imprinting in the variable expression of AHO.
- To correlate the mode of inheritance with the clinical presentation of the disorder.
Main Methods:
- A review of published case reports of Albright's hereditary osteodystrophy (AHO) was conducted.
- The analysis focused on families with at least two generations affected by AHO.
- Transmission patterns (maternal vs. paternal) were analyzed in relation to clinical expression.
Main Results:
- A significant excess of maternal transmission was observed in the reviewed AHO cases.
- Full expression of AHO, including hormone resistance (pseudohypoparathyroidism), was predominantly seen in maternally inherited cases.
- Partial expression of AHO (phenotype without hormone resistance) was more common in paternally inherited cases.
Conclusions:
- The findings strongly suggest the involvement of genomic imprinting in the expression of Albright's hereditary osteodystrophy (AHO).
- Maternal inheritance appears to be associated with a more complete phenotypic expression compared to paternal inheritance.
- Genomic imprinting may explain the variable expressivity of AHO and its associated hormonal abnormalities.